Page 118 - Fertility in Women with Rheumatoid Arthritis Vruchtbaarheid van vrouwen met reumatoïde artritis

Chapter 7
25. Su, H.I., et al., Comparability of antimullerian hormone levels among commercially available immunoassays. Fertil Steril, 2014. 101(6): p. 1766-72 e1.
26. Lie Fong, S., et al., Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab, 2012. 97(12): p. 4650-5.
27. Erler, N.S., et al., Dealing with missing covariates in epidemiologic studies: a comparison between multiple imputation and a full Bayesian approach. Stat Med, 2016. 35(17): p. 2955-74.
28. Willemze, A., et al., The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol, 2012. 8(3): p. 144-52.
29. Aletaha, D., et al., 2010 Rheumatoid arthritis classi cation criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum, 2010. 62(9): p. 2569-81.
30. Smolen, J.S., et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the rheumatic diseases, 2010. 69(6): p. 964-75.
31. D’Arpe, S., et al., Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review. Reprod Biomed Online, 2016. 33(4): p. 436-448.
32. Johnson, L.N., et al., Antimullerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception. Fertil Steril, 2014. 102(3): p. 774-781 e3.
116